GBT

Global Blood Therapeutics, Inc.

Delisted

GBT was delisted on the 4th of October, 2022.

75 hedge funds and large institutions have $229M invested in Global Blood Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 14 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
+7
Holders Change %
+10.29%
% of All Funds
2%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
20
Increased
36
Reduced
14
Closed
13
Calls
$17.6M
Puts
$10K
Net Calls
+$17.6M
Net Calls Change
+$17.6M
Name Holding Trade Value Shares
Change
Shares
Change %
RCM
76
RA Capital Management
Massachusetts
-$14.8M -457,142 Closed
GGHC
77
Gilder Gagnon Howe & Co
New York
-$9.6M -297,053 Closed
RG
78
Redmile Group
California
-$7.07M -218,718 Closed
MCM
79
Moore Capital Management
New York
-$1.29M -40,000 Closed
AllianceBernstein
80
AllianceBernstein
Tennessee
-$854K -26,416 Closed
Jane Street
81
Jane Street
New York
-$830K -25,679 Closed
SFM
82
Soros Fund Management
New York
-$679K -21,000 Closed
FAM
83
Fred Alger Management
New York
-$519K -16,050 Closed
MLICM
84
Metropolitan Life Insurance Company (MetLife)
New York
-$231K -7,158 Closed
RhumbLine Advisers
85
RhumbLine Advisers
Massachusetts
-$202K -6,255 Closed
PAM
86
Panagora Asset Management
Massachusetts
-$191K -5,908 Closed
Bank of Montreal
87
Bank of Montreal
Ontario, Canada
-$81K -2,500 Closed
PSC
88
Piper Sandler & Co
Minnesota
-$23K -700 Closed